UK’s health department expected to spend £1B in pharma trade deal with USnews2026-02-04T00:01:38+00:00February 4th, 2026|Endpoints News|
Novo expects sales to fall in 2026, triggering selloffnews2026-02-03T20:07:25+00:00February 3rd, 2026|Endpoints News|
‘Turning around the Titanic’: How the incoming PBM reforms will transform CMSnews2026-02-03T19:34:01+00:00February 3rd, 2026|Endpoints News|
China startup AccurEdit raises $75M for gene editing therapiesnews2026-02-03T16:13:27+00:00February 3rd, 2026|Endpoints News|
Daiichi ends work on an ADC; Layoffs at GSK’s R&D unitnews2026-02-03T15:30:08+00:00February 3rd, 2026|Endpoints News|
Ultragenyx unwraps data that may be central to its gene therapy resubmissionnews2026-02-03T13:00:48+00:00February 3rd, 2026|Endpoints News|
Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earningsnews2026-02-03T12:51:41+00:00February 3rd, 2026|Endpoints News|
Updated: Do Pfizer’s monthly GLP-1 data justify Metsera’s $10B price tag?news2026-02-03T12:30:48+00:00February 3rd, 2026|Endpoints News|
AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelonews2026-02-03T12:03:52+00:00February 3rd, 2026|Endpoints News|
